bioRxivCancer BiologyPreprint
ALKBH1 drives codon-biased, pro-oncogenic translation and tumor microenvironment remodeling in glioma via tRNA wobble oxidation
Atsushi Nakayashiki, Arata NagaiiD, Yuko IwasakiiD, Abdulrahman MousaiD, Moe Kumai, Munehiro Kimura, Shadi Al-MesitefiD, Hiroshi Kanno, Shota YamashitaiD, Daisuke AndoiD, Yoshiteru ShimodaiD, Masayuki KanamoriiD, Keisuke GodaiD, Hidenori EndoiD, Sherif RashadiD, Kuniyasu NiizumaiD
Abstract
Gliomas rely on translational plasticity to sustain heterogeneity, stemness, and immune evasion. Here we identify the tRNA dioxygenase ALKBH1 as a central regulator of codon-biased translation and tumor microenvironment remodeling. LC-MS/MS profiling of patient tumors revealed enrichment of ALKBH1-mediated wobble cytidine oxidation modifications in high-grade gliomas. Genetic perturbation demonstrated that ALKBH1 overexpression slows proliferation in vitro but worsens survival in vivo by promoting glioma stem-like and neuronal states and suppressing anti-tumor immunity. Ribosome profiling showed that ALKBH1 establishes an A/T-ending codon-biased translational program, enhancing decoding of rare leucine codons (TTA/TTG) and driving synthesis of pro-stemness transcripts. Single-cell RNA-seq analyses further revealed that ALKBH1 promotes glioma heterogeneity and induces neuronal cell clusters and rewires intercellular communication ECM-related signaling while dampening immune pathways and reducing immune infiltration. These findings establish a mechanistic link between tRNA oxidation, codon bias, and glioma aggressiveness, positioning ALKBH1 as a potential therapeutic target for glioma.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- assay: spatial transcriptomics
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: statistical model
- approach: deep learning
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- miRNA-mediated loss of m6A increases nascent translation in glioblastoma
J. P. Zepecki, D. Karambizi, … N. Tapinos·bioRxiv·Aug 28, 2020
- Glioblastoma Hijacks Astrocyte Ribosomes to Feul Malignancy through Translatome Reprogramming
Xujia Wu, Chen Zheng, … Nu Zhang·bioRxiv·Oct 29, 2026
- Local translation drives glioblastoma heterogeneity and tumor invasion
Nikolas Layer, Niklas Wißmann, … Varun Venkataramani·bioRxiv·May 6, 2026
- Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology
Durgesh Meena, Divya Shivakumar, … Sushmita Jha·Journal of Cellular PhysiologyPeer-reviewed·Mar 1, 2026
- Transcriptional Control of Brain Tumour Stem Cell by a Carbohydrate Binding Protein
A. Sharanek, A. Burban, … A. Jahani-Asl·bioRxiv·Apr 14, 2021
- Spatiotemporal heterogeneity of glioblastoma is dictated by microenvironmental interference
V. M. Ravi, P. Will, … D. H. Heiland·bioRxiv·Feb 16, 2021